Bioscience

Power3 Medical hits a grand slam at ICAD with four Alzheimer’s poster presentations

September 10, 2010

By Flinn Foundation

[Source: Market Wire] – Power3 Medical Products, Inc. (OTCBB:, a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, announced today that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

For more information: Power3 Medical Hits a Grand Slam at ICAD With Four Alzheimer’s Poster Presentations